This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR
Clinical trial NCT06595758 · COMPLETED
Trial details
- NCT number
- NCT06595758
- Sponsor
- Menoufia University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.